Galmed Pharmaceuticals Ltd. EOCN
3.63
0.01
0.28%
as of 25 Sep
- Market cap
- $3.8M
- P/E
- 0.0×
Follow EOCN
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
— | — | — | — |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
4.92 | 4.04 | 3.97 | 3.29 | |
Current Ratio |
7.98 | 6.55 | 7.71 | 4.16 | |
Net Debt/EBITDA |
5.56 | 3.65 | 3.84 | 3.20 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.02 | 0.40 | 1.33 | 0.78 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.35 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(2.84) | (3.61) | (3.08) | (2.23) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(2.84) | (3.61) | (3.08) | (2.23) | |
Cash per Share |
17.02 | 20.66 | 9.47 | 9.37 | |
Shareholders Equity per Share |
28.00 | 29.29 | 16.93 | 13.38 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
28.00 | 29.29 | 16.93 | 13.38 | |
Free Cash Flow |
(1.93) | (1.94) | (2.54) | (2.13) | |
Working Capital |
17.25 | 15.78 | 13.95 | 8.90 | |
Net Current Asset Value |
17.25 | 15.78 | 13.95 | 6.17 | |
EV/EBIT |
— | — | — | — | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Receivables |
0.49 | 0.51 | 0.45 | 0.38 | |
Average Payables |
1.51 | 1.66 | 1.52 | 1.63 | |
Average Assets |
21.27 | 18.56 | 17.36 | 20.61 | |
Average Common Equity |
18.77 | 16.05 | 15.41 | 16.63 |
Columns are period end dates